In this podcast, Steven Kleiboeker (Vice-President of Research and Development at Viracor Eurofins BioPharma Services, Kansas City, MO, USA) discusses…
Browsing: In the Zone
This infographic highlights tips to overcome challenges in the areas of PK analysis, large molecule analysis by LC–MS/MS and prodrug analysis.
Assay development enables a drug or biochemical to be tested or measured. When analyzing a peptide of interest, it is important to choose and develop assays that are specific, sensitive and robust. There are many challenges when developing assays.
In this podcast we discuss the challenges faced by the modern bioanalyst and some of the innovative solutions that have been put into practice by scientists at Alturas Analytics (ID, USA).
Bioanalysis is a critical part of the discovery and development of peptide therapeutics. In this In the Zone, we explore key bioanalytical challenges of peptide bioanalysis sample preparation.
Antibody–drug conjugates (ADCs) combine the best of two modalities: toxic efficacy and antibody specificity. This infographic describes various mass spectrometry-based strategies Frontage have successfully applied in the bioanalysis of ADCs for clinical and preclinical studies.
In this interview, David Harris (Charles River Laboratories; NC, USA) discusses the current global landscape for cell therapy, associated safety concerns and challenges, and preclinical animal models that are used to evaluate cellular therapies.